FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to laboratory diagnostics of internal diseases. Additionally in patients blood plasma determined is total quantity of nitrogen oxide, and if NO value is more or equal 17 mcmol/l chronic viral hepatitis is diagnosed, if amount of NO is less than 17 mcmol/l - liver cirrhosis.
EFFECT: providing non-traumatic, sensitive, specific and efficient deferential diagnostics of chronic viral hepatitis and liver cirrhosis of viral genesis by degree of endothelium dysfunction.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIATED DIAGNOSTICS OF CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | 2008 |
|
RU2383024C1 |
| METHOD FOR TREATING CHRONIC HEPATITIS | 2005 |
|
RU2282457C1 |
| METHOD FOR DETERMINING AVERAGE RATE OF FORMATION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2020 |
|
RU2739687C1 |
| DIAGNOSTIC TECHNIQUE FOR STAGE OF CHRONIC HEPATITIS C IN RNA-HCV "+" PATIENTS | 2012 |
|
RU2486516C1 |
| DIAGNOSTIC TECHNIQUE FOR DRUG-INDUCED LIVER INJURY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2695021C1 |
| METHOD FOR VERIFICATION OF SYMPTOMATIC AND MINIMAL HEPATIC ENCEPHALOPATHY IN CHRONIC HEPATITIS AND LIVER CIRRHOSIS | 2022 |
|
RU2792568C1 |
| METHOD FOR ASSESSING PROBABILITY OF DEVELOPING NEPHRITIS IN DIFFUSE LIVER DISEASES | 2022 |
|
RU2792321C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATITIS AND HEPATIC CIRRHOSIS | 2012 |
|
RU2516970C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF DIFFUSE DISEASES OF LIVER | 2011 |
|
RU2482792C1 |
| METHOD FOR DIAGNOSIS OF AUTOIMMUNE LIVER INJURY IN PATIENT WITH CHRONIC HEPATITIS | 2003 |
|
RU2247387C1 |
